Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Recent patents cover new therapeutic agents for cancer

March 30, 2007

rNAPc2 receives fast track designations in metastatic colorectal cancer

March 29, 2007

Terameprocol studied in phase I/II trial for brain tumors

March 29, 2007

OncoGel studied in phase I/II GBM study

March 29, 2007

Novel antimitotics targeting the kinesin spindle protein presented at the ACS

March 29, 2007

European orphan drug designation for enzastaurin in DLBCL

March 28, 2007

Semafore's PI3K inhibitor studied in phase I for solid tumors

March 28, 2007

CHR-2797 begins phase II for AML in elderly patients

March 28, 2007

Celsion files for SPA for ThermoDox

March 28, 2007

Satraplatin improves pain and PSA responses in phase III trial

March 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...